
The key ingredient in blockbuster weight-loss drugs could help people manage a serious liver condition before it becomes life-threatening, a new trial has found.
The results, published on Wednesday in the New England Journal of Medicine, offer the latest evidence that weight loss drugs could help with a host of health issues beyond type 2 diabetes and obesity, which is what they’re currently approved for in the European Union.